PROCEPT BioRobotics (PRCT) Income from Continuing Operations (2020 - 2026)
PROCEPT BioRobotics (PRCT) reported Income from Continuing Operations of 31638000.0 for Q1 2026, down 27.9% year-over-year from 43879188.5 in Q1 2025, and down 6.69% quarter-over-quarter from 29655000.0 in Q4 2025.
PROCEPT BioRobotics (PRCT) Income from Continuing Operations (2020 - 2026) Analysis & Trends
PROCEPT BioRobotics (PRCT) has 7 years of Income from Continuing Operations data on file, last reported at 31638000.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 31638000.0, down 27.9% year-over-year; the trailing twelve-month figure through Mar 2026 was 102282000.0 (down 13.87% YoY), and the FY2025 annual result was 95572000.0, down 4.55% from the prior year.
- Income from Continuing Operations slipped to 31638000.0 in Q1 2026 per PRCT's latest filing, from 29655000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 17185000.0 in Q1 2022 and troughed at 31638000.0 in Q1 2026.
- A 5-year average of 23986764.71 and a median of 24737000.0 in 2025 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2023 and 2024: Income from Continuing Operations slumped 65.75% in 2023, then jumped 32.58% in 2024.
- A 5-year view of Income from Continuing Operations shows it stood at 24914000.0 in 2022, then declined by 10.07% to 27424000.0 in 2023, then jumped by 32.58% to 18488000.0 in 2024, then slumped by 60.4% to 29655000.0 in 2025, then dropped by 6.69% to 31638000.0 in 2026.
- Business Quant data shows PRCT's Income from Continuing Operations at 31638000.0 in Q1 2026, 29655000.0 in Q4 2025, and 21411000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | PROCEPT BioRobotics | 1.23 Bn | 985.73 Mn | 53.95 Mn | -31.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.64 Mn |
| Dec 31, 2025 | -29.66 Mn |
| Sep 30, 2025 | -21.41 Mn |
| Jun 30, 2025 | -19.58 Mn |
| Mar 31, 2025 | -24.74 Mn |
| Dec 31, 2024 | -18.49 Mn |
| Sep 30, 2024 | -20.97 Mn |
| Jun 30, 2024 | -25.63 Mn |
| Mar 31, 2024 | -25.96 Mn |
| Dec 31, 2023 | -27.42 Mn |
| Sep 30, 2023 | -24.62 Mn |
| Jun 30, 2023 | -25.29 Mn |
| Mar 31, 2023 | -28.48 Mn |
| Dec 31, 2022 | -24.91 Mn |
| Sep 30, 2022 | -22.61 Mn |
| Jun 30, 2022 | -19.18 Mn |
| Mar 31, 2022 | -17.19 Mn |
| Dec 31, 2021 | -18.35 Mn |
| Sep 30, 2021 | -14.10 Mn |
| Jun 30, 2021 | -14.58 Mn |